Holder JL Jr, Quach MM

The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK3 loss-of-function mutations.

Epilepsia 57:1651-1659 (2016)
DOI:10.1111/epi.13506

Costales JL, Kolevzon A

Phelan-McDermid Syndrome and SHANK3: Implications for Treatment.

Neurotherapeutics 12:620-30 (2015)
DOI:10.1007/s13311-015-0352-z

Gauthier J, Champagne N, Lafreniere RG, Xiong L, Spiegelman D, Brustein E, Lapointe M, Peng H, Cote M, Noreau A, Hamdan FF, Addington AM, Rapoport JL, Delisi LE, Krebs MO, Joober R, Fathalli F, Mouaffak F, Haghighi AP, Neri C, Dube MP, Samuels ME, Marineau C, Stone EA, Awadalla P, Barker PA, Carbonetto S, Drapeau P, Rouleau GA

De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia.

Proc Natl Acad Sci U S A 107:7863-8 (2010)
DOI:10.1073/pnas.0906232107